Khoury S J, Lider O, al-Sabbagh A, Weiner H L
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Cell Immunol. 1990 Dec;131(2):302-10. doi: 10.1016/0008-8749(90)90256-q.
Oral administration of myelin basic protein (MBP) suppresses experimental autoimmune encephalomyelitis (EAE) in Lewis rats immunized with MBP in Freund's adjuvant. The immunomodulator bacterial lipopolysaccharide (LPS) when given orally in conjunction with MBP enhances the protective effects of MBP feeding in EAE. This synergy was achieved only following oral administration of LPS but not following subcutaneous injection. In contrast, subcutaneous administration of LPS abrogated oral tolerance. A synergism between oral LPS and MBP was also demonstrated for antigen-specific suppression of delayed type hypersensitivity (DTH) responses. Antibody responses to MBP were suppressed by oral administration of MBP but not by MBP plus LPS. The lipid A moeity of LPS mimicked the effects of LPS on disease protection and DTH suppression. These data demonstrate that adjuvants can enhance the induction of antigen-specific oral tolerance for suppression of cell-mediated experimental autoimmune responses.
口服髓鞘碱性蛋白(MBP)可抑制在弗氏佐剂中用MBP免疫的Lewis大鼠的实验性自身免疫性脑脊髓炎(EAE)。免疫调节剂细菌脂多糖(LPS)与MBP联合口服时,可增强MBP喂养对EAE的保护作用。这种协同作用仅在口服LPS后实现,皮下注射则未出现。相反,皮下注射LPS消除了口服耐受性。口服LPS和MBP之间的协同作用在抗原特异性抑制迟发型超敏反应(DTH)中也得到了证实。口服MBP可抑制对MBP的抗体反应,但MBP加LPS则无此作用。LPS的脂质A部分模拟了LPS对疾病保护和DTH抑制的作用。这些数据表明,佐剂可增强抗原特异性口服耐受性的诱导,以抑制细胞介导的实验性自身免疫反应。